4.53

2.16% -0.10

Rezolute Inc (RZLT)

Overview News Price History Financials Discussions Forecast Stock Split

Rezolute Inc stock is traded at $4.53, with a volume of 357.98K. It is down -2.16% in the last 24 hours and down -7.93% over the past month. Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Previous Close:

$4.63

Open:

$4.79

24h Volume:

357.98K

Relative Volume:

0.81

Market Cap:

$274.23M

Revenue:

Net Income/Loss:

$-69.31M

P/E Ratio:

-3.5669

EPS:

-1.27

Net Cash Flow:

$-62.80M

1W Performance:

-1.74%

1M Performance:

-7.93%

6M Performance:

+4.14%

1Y Performance:

+208.16%

1-Day Range:

$4.48

$4.79

1-Week Range:

$4.48

$4.80

52-Week Range:

$1.49

$6.1856

Rezolute Inc Stock (RZLT) Company Profile

Name

Rezolute Inc

Sector

Healthcare (1169)

Industry

Biotechnology (678)

Phone

650-206-4507

Address

275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY

Employee

Twitter

Next Earnings Date

2025-02-11

Latest SEC Filings

RZLT's Discussions on Twitter

Compare RZLT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RZLT Rezolute Inc	4.53	274.23M	0	-69.31M	-62.80M	-1.27
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-05-24	Initiated	Wedbush	Outperform
Aug-27-24	Initiated	Guggenheim	Buy
Jul-17-24	Initiated	BTIG Research	Buy
Jun-04-24	Initiated	Craig Hallum	Buy
Apr-09-24	Initiated	Maxim Group	Buy
Aug-02-22	Resumed	Canaccord Genuity	Buy
Jun-15-22	Initiated	Cantor Fitzgerald	Overweight
Sep-08-21	Initiated	ROTH Capital	Buy
May-27-21	Initiated	Oppenheimer	Outperform
May-25-21	Initiated	H.C. Wainwright	Buy

View All

Rezolute Inc Stock (RZLT) Latest News

Feb 21, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria

Feb 21, 2025

Feb 20, 2025

Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India

Feb 20, 2025

Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey

Feb 20, 2025

JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat

Feb 18, 2025

Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha

Feb 18, 2025

Feb 17, 2025

Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN

Feb 17, 2025

What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World

Feb 17, 2025

What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat

Feb 17, 2025

What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World

Feb 17, 2025

Feb 16, 2025

Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat

Feb 16, 2025

Rezolute’s Strategic Advances in Rare Disease Therapies - MSN

Feb 16, 2025

Feb 14, 2025

Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat

Feb 14, 2025

Feb 13, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia

Feb 13, 2025

JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN

Feb 13, 2025

Feb 12, 2025

Rezolute Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 12, 2025